Synonyms: BMS986299 | compound 112 [WO2018152396A1]
Compound class:
Synthetic organic
Comment: BMS-986299 is a NLRP3 inflammasome modulator (agonist) [1]. It induces production of IL-1β and IL-8 and it is being examined for immunomodulatory and antineoplastic activities. Enhanced IL-8 is predicted to induce tumouricidal activity of natural killer (NK) cells against cancer cells.
|
|
References |
1. Glick G, Ghosh S, Roush WR, Olhava EJ, O'Malley D. (2018)
Substituted imidazo-quinolines as nlrp3 modulators. Patent number: WO2018152396A1. Assignee: Innate Tumor Immunity Inc.. Priority date: 17/02/2017. Publication date: 23/08/2018. |